Skip to content

Trial Summary

 This is a Phase 1 open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in people with micro satellite-stable (MSS) colorectal or gastroesophageal cancer metastatic to liver, or advanced ovarian cancer.



ACTRN/NCT /ethics:


Scientific title:

Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours

Sponsor / Cooperative group:

ImmVirx Pty Ltd

Trial & Patient Characteristics

Cancer TypeAll
Trial TypeTreatment
PhasePhase I
Age Range18 to 85 years
Tumour Stream -
Cancer Stage-
Anticipated Start Date2023-02-17
Anticipated End Date2024-09-01

Participating Hospitals

HospitalThe Queen Elizabeth Hospital
Clinical Trial CoordinatorPamela Cooper
Phone08 8222 6140
Principal InvestigatorTim Price
Recruitment StatusRecruiting